NCT01517100View on ClinicalTrials.gov

The Role of Endocannabinoids in Insulin Production and Action

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

January 5, 2012

Primary Completion Date

October 6, 2014

Study Completion Date

October 6, 2014

Conditions
Healthy Volunteers
Interventions
OTHER

Nabilone

CB agonist

DRUG

CP-945,598

Cannabinoid Receptor 1 antagonist

OTHER

hyperglycemic clamp

assesses beta cell response

OTHER

euglycemic-hyperinsulinemic clamp

measures insulin sensitivity

OTHER

Nabilone

cannabinoid receptor agonist

Trial Locations (1)

21224

National Institute of Aging, Clinical Research Unit, Baltimore

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT01517100 - The Role of Endocannabinoids in Insulin Production and Action | Biotech Hunter | Biotech Hunter